Skip to main content
. 2014 Sep 17;4(9):e005223. doi: 10.1136/bmjopen-2014-005223

Table 1.

Demographic and clinical characteristics of the Regione Emilia-Romagna population, overall and by risk category

  Total population*
Very high risk†
High risk†
3 726 380
114 255
134 610
Number Per cent Number Per cent Number Per cent
Gender
 Male 1 788 048 48.0 54 357 47.6 61 803 45.9
 Female 1 938 332 52.0 59 898 52.4 72 807 54.1
Age groups
 18–24 258 338 6.9 76 0.1 105 0.1
 25–34 499 786 13.4 302 0.3 391 0.3
 35–44 732 626 19.7 1137 1.0 1198 0.9
 45–54 676 047 18.1 2612 2.3 2485 1.8
 55–64 550 689 14.8 5391 4.7 5287 3.9
 65–74 482 346 12.9 13 154 11.5 14 471 10.8
 75–84 364 369 9.8 33 430 29.3 44 857 33.3
 85+ 162 179 4.4 58 153 50.9 65 816 48.9
Number of chronic conditions
 0–1 2 775 888 74.5 8176 7.2 24 618 18.3
 2 or more 950 492 25.5 106 079 92.8 109 992 81.7
 5 or more 99 337 2.7 45 445 39.8 20 576 15.3
Selected conditions/body systems
 Cancer 99 328 2.7 23 872 20.9 14 305 10.6
 Cardiovascular 967 796 26.0 96 157 84.2 103 749 77.1
 Male genitourinary‡ 130 609 7.3 14 616 26.9 16 776 27.1
 Ear, nose, throat 5364 0.1 240 0.2 242 0.2
 Endocrine 429 528 11.5 40 653 35.6 37 471 27.8
 Eye 114 117 3.1 9,558 8.4 13 478 10.0
 Gastrointestinal 580 946 15.6 74 718 65.4 66 305 49.3
 Gynaecological§ 21 806 1.1 333 0.6 405 0.6
 Haematological 45 022 1.2 15 353 13.4 6591 4.9
 Hepatobiliary 24 785 0.7 6,477 5.7 3306 2.5
 Immunological 3281 0.1 464 0.4 273 0.2
 Infectious disease 4723 0.1 2207 1.9 727 0.5
 Musculoskeletal 419 184 11.2 43 436 38.0 41 000 30.5
 Neurological 173 751 4.7 34 494 30.2 24 838 18.5
 Psychological 291 308 7.8 43 387 38.0 33 715 25.0
 Respiratory 176 830 4.7 39 082 34.2 21 763 16.2
 Skin 28 339 0.8 7,645 6.7 3,008 2.2
 Urogenital 37 728 1.0 16 501 14.4 5,740 4.3
Polypharmacy¶ 609 278 16.4 92 153 80.7 92 156 68.5
Any potentially inappropriate medications (age 65 years or older)** 257 033 25.5 51 055 48.7 49 003 39.2

*Adults (age 18 or older) and alive at 31 December 2011.

†‘Very high risk’ was defined as patients with a predicted risk of hospitalisation or death in the following year of ≥25% while ‘high risk’ was defined as patients with a predicted risk of hospitalisation of 15–24%.

‡Men only.

§Women only.

¶Polypharmacy is defined as the simultaneous use of five or more active ingredients for at least 15 consecutive days.

**The list of potentially inappropriate medications can be found in ref. 11.